Hiroo Kasahara Selected Research

Hypobetalipoproteinemias (Hypobetalipoproteinemia)

1/2021

Recurrent Lobar Hemorrhages and Multiple Cortical Superficial Siderosis in a Patient of Alzheimer's Disease With Homozygous APOE ε2 Allele Presenting Hypobetalipoproteinemia and Pathological Findings of 18F-THK5351 Positron Emission Tomography: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroo Kasahara Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 09/2011
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 12/2012
2	Neuroinflammatory Diseases 01/2024 - 01/2021
2	Multiple System Atrophy 01/2024 - 01/2023
2	Cognitive Dysfunction 01/2019 - 09/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Dementia (Dementias) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Neuronal intranuclear inclusion disease 01/2023
1	Leukoencephalopathies 01/2023
1	Tauopathies 01/2023
1	Parkinsonian Disorders (Parkinsonism) 01/2023
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2023
1	Myasthenia Gravis 01/2022
1	Thymoma (Thymic Carcinoma) 01/2022
1	Type 4H Charcot-Marie-Tooth Disease 12/2021
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 01/2021
1	Hemorrhage 01/2021
1	Siderosis 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Cerebral Hemorrhage 01/2021
1	Radiculopathy (Radiculopathy, Cervical) 12/2020
1	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 01/2020
1	Brain Diseases (Brain Disorder) 12/2012
1	Photophobia (Light Sensitivity) 12/2012
1	Infarction (Infarctions) 12/2007

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 01/2019
2	Amyloid beta-PeptidesIBA 01/2021 - 12/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
2	ApolipoproteinsIBA 01/2021 - 12/2012
1	SynucleinsIBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024
1	ioflupaneIBA 01/2023
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2023
1	polyglycineIBA 01/2023
1	Threonine (L-Threonine)FDA Link 01/2023
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Rho Guanine Nucleotide Exchange FactorsIBA 12/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	THK5351IBA 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2020
1	Valosin Containing ProteinIBA 01/2020
1	CytosineIBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	Amino Acids FDA Link 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	ThymineIBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2011
1	BenzodiazepinesIBA 12/2007
1	Carbamazepine (Tegretol)FDA LinkGeneric 12/2007

Therapy/Procedure

1	Immunotherapy 01/2022